TD Securities resumed coverage of Docebo (DCBO) with a Buy rating and $37 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
- Docebo’s Earnings Call Highlights Strategic Growth and Challenges
- Docebo price target raised to $46 from $43 at Canaccord
- Docebo Reports Strong Q2 2025 Financial Results
- Optimistic Buy Rating for Docebo Amid Strong Performance and Innovative Growth Prospects
- Docebo reports Q2 adjusted EPS 29c, consensus 22c